Total Payments
$1,491
2024 Payments
$144.97
Companies
8
Transactions
24
Medicare Patients
1,366
Medicare Billing
$88,332
Payment Breakdown by Category
Travel$909.98 (61.0%)
Food & Beverage$580.68 (39.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Travel and Lodging | $909.98 | 5 | 61.0% |
| Food and Beverage | $580.68 | 19 | 39.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Allergan, Inc. | $1,093 | 10 | $0 (2021) |
| ABBVIE INC. | $133.36 | 6 | $0 (2024) |
| Alcon Vision LLC | $108.02 | 1 | $0 (2022) |
| Dompe US, Inc. | $51.01 | 2 | $0 (2024) |
| Tarsus Pharmaceuticals, Inc. | $35.57 | 1 | $0 (2024) |
| Bausch & Lomb Americas Inc. | $32.20 | 2 | $0 (2024) |
| BIOTISSUE HOLDINGS, INC. | $21.84 | 1 | $0 (2023) |
| RxSight Inc | $15.42 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $144.97 | 6 | Dompe US, Inc. ($51.01) |
| 2023 | $67.06 | 3 | AbbVie Inc. ($45.22) |
| 2022 | $185.39 | 5 | Alcon Vision LLC ($108.02) |
| 2021 | $973.55 | 9 | Allergan, Inc. ($973.55) |
| 2018 | $119.69 | 1 | Allergan Inc. ($119.69) |
All Payment Transactions
24 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/13/2024 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $26.19 | General |
| Category: EYE CARE | ||||||
| 10/24/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $35.57 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 09/09/2024 | Bausch & Lomb Americas Inc. | XIIDRA (Drug) | Food and Beverage | In-kind items and services | $13.60 | General |
| Category: Ophthalmology | ||||||
| 09/06/2024 | Dompe US, Inc. | OXERVATE (Drug) | Food and Beverage | In-kind items and services | $33.53 | General |
| Category: SOLUTION/ DROPS | ||||||
| 06/26/2024 | Bausch & Lomb Americas Inc. | MIEBO (Drug) | Food and Beverage | In-kind items and services | $18.60 | General |
| Category: Ophthalmology | ||||||
| 04/24/2024 | Dompe US, Inc. | OXERVATE (Drug) | Food and Beverage | In-kind items and services | $17.48 | General |
| Category: SOLUTION/ DROPS | ||||||
| 12/07/2023 | AbbVie Inc. | LUMIGAN (Drug), ALPHAGAN P | Food and Beverage | In-kind items and services | $28.68 | General |
| Category: EYE CARE | ||||||
| 04/13/2023 | AbbVie Inc. | LUMIGAN (Drug), ALPHAGAN P, VUITY | Food and Beverage | In-kind items and services | $16.54 | General |
| Category: EYE CARE | ||||||
| 01/09/2023 | BIOTISSUE HOLDINGS, INC. | PROKERA (Device), AMNIOGRAFT | Food and Beverage | In-kind items and services | $21.84 | General |
| Category: HUMAN TISSUE PRODUCTS | ||||||
| 10/12/2022 | Alcon Vision LLC | HYDRUS Microstent (Device) | Food and Beverage | In-kind items and services | $108.02 | General |
| Category: Ophthalmology | ||||||
| 08/23/2022 | ABBVIE INC. | VUITY (Drug) | Food and Beverage | In-kind items and services | $22.57 | General |
| Category: OPHTHALMOLOGY | ||||||
| 06/28/2022 | ABBVIE INC. | HUMIRA (Biological) | Food and Beverage | In-kind items and services | $23.56 | General |
| Category: IMMUNOLOGY | ||||||
| 06/21/2022 | ABBVIE INC. | VUITY (Drug) | Food and Beverage | In-kind items and services | $15.82 | General |
| Category: OPHTHALMOLOGY | ||||||
| 06/14/2022 | RxSight Inc | LIGHT ADJUSTABLE LENS (LAL) AND LIGHT DELIVERY DEVICE (LDD) (Device) | Food and Beverage | In-kind items and services | $15.42 | General |
| Category: Ophthalmology | ||||||
| 09/25/2021 | Allergan, Inc. | XEN GLAUCOMA TREATMENT SYSTEM (Device) | Travel and Lodging | In-kind items and services | $661.40 | General |
| Category: GLAUCOMA | ||||||
| 09/25/2021 | Allergan, Inc. | XEN GLAUCOMA TREATMENT SYSTEM (Device) | Travel and Lodging | In-kind items and services | $141.76 | General |
| Category: GLAUCOMA | ||||||
| 09/25/2021 | Allergan, Inc. | XEN GLAUCOMA TREATMENT SYSTEM (Device) | Travel and Lodging | In-kind items and services | $52.82 | General |
| Category: GLAUCOMA | ||||||
| 09/25/2021 | Allergan, Inc. | XEN GLAUCOMA TREATMENT SYSTEM (Device) | Travel and Lodging | In-kind items and services | $30.00 | General |
| Category: GLAUCOMA | ||||||
| 09/25/2021 | Allergan, Inc. | XEN GLAUCOMA TREATMENT SYSTEM (Device) | Travel and Lodging | In-kind items and services | $24.00 | General |
| Category: GLAUCOMA | ||||||
| 09/25/2021 | Allergan, Inc. | XEN GLAUCOMA TREATMENT SYSTEM (Device) | Food and Beverage | Cash or cash equivalent | $11.74 | General |
| Category: GLAUCOMA | ||||||
| 09/25/2021 | Allergan, Inc. | XEN GLAUCOMA TREATMENT SYSTEM (Device) | Food and Beverage | Cash or cash equivalent | $4.86 | General |
| Category: GLAUCOMA | ||||||
| 09/24/2021 | Allergan, Inc. | XEN GLAUCOMA TREATMENT SYSTEM (Device) | Food and Beverage | Cash or cash equivalent | $40.98 | General |
| Category: GLAUCOMA | ||||||
| 09/24/2021 | Allergan, Inc. | XEN GLAUCOMA TREATMENT SYSTEM (Device) | Food and Beverage | Cash or cash equivalent | $5.99 | General |
| Category: GLAUCOMA | ||||||
| 11/14/2018 | Allergan Inc. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $119.69 | General |
| Category: RETINA | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 745 | 972 | $171,253 | $50,174 |
| 2022 | 9 | 528 | 576 | $90,267 | $31,818 |
| 2021 | 5 | 93 | 94 | $12,273 | $6,341 |
Total Patients
1,366
Total Services
1,642
Medicare Billing
$88,332
Procedure Codes
25
All Medicare Procedures & Services
25 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 92014 | Established patient complete exam of visual system | Office | 2023 | 214 | 241 | $65,070 | $19,070 | 29.3% |
| 92012 | Established patient problem focused exam of visual system | Office | 2023 | 116 | 251 | $47,941 | $14,722 | 30.7% |
| 92004 | New patient complete exam of visual system | Office | 2023 | 46 | 46 | $14,812 | $3,804 | 25.7% |
| 92134 | Imaging of retina | Office | 2023 | 119 | 131 | $11,397 | $3,580 | 31.4% |
| 92083 | Exam of visual field with extended testing | Office | 2023 | 65 | 78 | $10,374 | $3,050 | 29.4% |
| 92133 | Imaging of optic nerve | Office | 2023 | 74 | 94 | $7,426 | $2,126 | 28.6% |
| 68761 | Closure of tear duct opening using plug | Office | 2023 | 16 | 19 | $6,061 | $1,887 | 31.1% |
| 92020 | Exam of the internal drainage system of eye | Office | 2023 | 49 | 54 | $3,240 | $876.89 | 27.1% |
| 92002 | New patient problem focused exam of visual system | Office | 2023 | 12 | 12 | $2,208 | $463.72 | 21.0% |
| 92136 | Measurement of corneal curvature and depth of eye | Office | 2023 | 14 | 26 | $1,964 | $452.38 | 23.0% |
| 76514 | Ultrasound scan of cornea to determine thickness | Office | 2023 | 20 | 20 | $760.00 | $141.10 | 18.6% |
| 92014 | Established patient complete exam of visual system | Office | 2022 | 118 | 119 | $30,510 | $10,494 | 34.4% |
| 92012 | Established patient problem focused exam of visual system | Office | 2022 | 64 | 91 | $15,706 | $5,768 | 36.7% |
| 92004 | New patient complete exam of visual system | Office | 2022 | 64 | 64 | $16,638 | $5,115 | 30.7% |
| 92134 | Imaging of retina | Office | 2022 | 139 | 141 | $10,509 | $3,759 | 35.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 34 | 42 | $5,136 | $2,333 | 45.4% |
| 92083 | Exam of visual field with extended testing | Office | 2022 | 38 | 42 | $4,906 | $1,902 | 38.8% |
| 92133 | Imaging of optic nerve | Office | 2022 | 38 | 41 | $2,909 | $1,034 | 35.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 12 | 13 | $2,783 | $924.09 | 33.2% |
| 92020 | Exam of the internal drainage system of eye | Office | 2022 | 21 | 23 | $1,170 | $486.98 | 41.6% |
| 92004 | Eye and medical examination for diagnosis and treatment, new patient, 1 or more visits | Office | 2021 | 23 | 23 | $4,991 | $2,414 | 48.4% |
| 92014 | Eye and medical examination for diagnosis and treatment, established patient, 1 or more visits | Office | 2021 | 13 | 13 | $2,340 | $1,142 | 48.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 14 | 15 | $1,665 | $1,045 | 62.7% |
| 92134 | Diagnostic imaging of retina | Office | 2021 | 31 | 31 | $1,789 | $920.40 | 51.4% |
| 92012 | Eye and medical examination for diagnosis and treatment, established patient | Office | 2021 | 12 | 12 | $1,488 | $819.12 | 55.0% |
About Katia Chavez, MD MPH
Katia Chavez, MD MPH is a Ophthalmology healthcare provider based in Albuquerque, New Mexico. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/27/2016. The National Provider Identifier (NPI) number assigned to this provider is 1740642891.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Katia Chavez, MD MPH has received a total of $1,491 in payments from pharmaceutical and medical device companies, with $144.97 received in 2024. These payments were reported across 24 transactions from 8 companies. The most common payment nature is "Travel and Lodging" ($909.98).
As a Medicare-enrolled provider, Chavez has provided services to 1,366 Medicare beneficiaries, totaling 1,642 services with total Medicare billing of $88,332. Data is available for 3 years (2021–2023), covering 25 distinct procedure/service records.
Ad
Practice Information
- Specialty Ophthalmology
- Other Specialties Ophthalmology, General Practice
- Location Albuquerque, NM
- Active Since 03/27/2016
- Last Updated 08/22/2024
- Taxonomy Code 207W00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1740642891
Products in Payments
- XEN GLAUCOMA TREATMENT SYSTEM (Device) $973.55
- OZURDEX (Drug) $119.69
- HYDRUS Microstent (Device) $108.02
- LUMIGAN (Drug) $71.41
- OXERVATE (Drug) $51.01
- VUITY (Drug) $38.39
- XDEMVY (Drug) $35.57
- HUMIRA (Biological) $23.56
- PROKERA (Device) $21.84
- MIEBO (Drug) $18.60
- LIGHT ADJUSTABLE LENS (LAL) AND LIGHT DELIVERY DEVICE (LDD) (Device) $15.42
- XIIDRA (Drug) $13.60
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Ophthalmology Doctors in Albuquerque
John Pitcher, M.d, M.D
Ophthalmology — Payments: $351,399
Ophthalmology $351,399
Robert Melendez, M.d, M.D
Ophthalmology — Payments: $260,758
Ophthalmology $260,758
Dr. Christopher Roybal, M.d, M.D
Ophthalmology — Payments: $53,047
Ophthalmology $53,047
Stephen Coleman, Md, MD
Ophthalmology — Payments: $15,456
Ophthalmology $15,456
Rachel Davis
Ophthalmology — Payments: $13,286
Ophthalmology $13,286
Arup Das, Md, MD
Ophthalmology — Payments: $11,111
Ophthalmology $11,111